首页> Experimental Neurology> Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.

Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.

导出原文传递

翻译打印收藏纠错

第一作者： Iravani MM

作者： Iravani MM ^[1] ; Sadeghian M ; Leung CC ; Tel BC ; Rose S ; Schapira AH ; Jenner P

作者单位： Neurodegenerative Disease Research Centre, School of Health and Biomedical Sciences, King's College, London SE1 1UL, UK. ^[1]

关键词 Amphetamine Animals Behavior Animal Benzothiazoles Cell Count Cell Death 苯丙胺动物行为细胞计数细胞死亡多巴胺多巴胺激动剂多巴胺摄取抑制剂

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Experimental Neurology

2008年212卷2期

522-531页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Experimental Neurology

2008年212卷2期

522-531页

检索历史清除

Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.

Experimental Neurology

相似文献

同项目论文

Experimental Neurology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.

Experimental Neurology

相似文献

同项目论文

Experimental Neurology

相关期刊

检索历史清除